Our Pricing

Why Wegovy Stops Working and What to Do Next

Published on: June 03, 2026

If wegovy stopped working uk for you, you're not alone—weight loss plateaus affect many patients after initial success. At Cured Pharmacy, our UK-registered clinical team can assess whether adjusting your dose, optimising your treatment plan, or exploring alternative options may help you continue your weight management journey.

Why Wegovy Stops Working: Understanding Weight Loss Plateaus

Weight loss plateaus on Wegovy (semaglutide) are a recognised clinical phenomenon, not treatment failure. After the initial rapid weight reduction phase—typically 15-20% of body weight in the first 6-9 months—your metabolism adapts to lower caloric intake and your body's set point begins to resist further change [1]. This adaptive thermogenesis is a normal physiological response that affects all weight loss interventions, not just GLP-1 receptor agonists.

In the STEP clinical trial programme, researchers observed that most patients reached their maximum weight loss between weeks 60 and 68, after which weight stabilised rather than continuing to decline [1]. This plateau doesn't mean Wegovy has stopped working—it means you've reached a new equilibrium where the medication is maintaining your weight loss against your body's natural tendency to regain. Understanding this distinction is crucial for setting realistic expectations and deciding on next steps.

Common Reasons Wegovy Appears Less Effective

Beyond natural metabolic adaptation, several factors can reduce Wegovy's effectiveness over time. Dietary habits often gradually drift from the structured approach that worked initially—portion sizes creep upward, snacking increases, and the novelty of appetite suppression wears off as patients become accustomed to the sensation [2]. The medication still reduces hunger signals, but behavioural patterns can override these physiological cues.

Inadequate dosing is another frequent culprit. Some patients never reach the full 2.4mg maintenance dose due to side effects or supply interruptions, remaining on 1.7mg or lower doses that may not provide optimal weight management for their individual physiology [1]. Additionally, certain medications—particularly some antidepressants, antipsychotics, and corticosteroids—can counteract Wegovy's effects by promoting weight gain through different metabolic pathways.

Medication Interactions and Absorption Issues

Wegovy's absorption can be affected by injection technique and site rotation. Injecting repeatedly into the same area causes lipohypertrophy—thickened fatty tissue that impairs drug absorption [2]. Our clinical team at Cured Pharmacy reviews proper injection technique during consultations to ensure you're achieving optimal bioavailability from each dose.

Solutions When Wegovy Stopped Working UK: Clinical Approaches

If you've genuinely plateaued on the maximum 2.4mg Wegovy dose for 12+ weeks, several evidence-based strategies can help. First, our UK prescribers assess whether you've reached the full maintenance dose—many patients benefit simply from completing the dose escalation schedule they may have paused due to temporary side effects or supply issues. All Wegovy doses are currently available at Cured Pharmacy from £79.00, allowing uninterrupted treatment progression.

For patients already on maximum dosing, combining Wegovy with structured behavioural interventions often breaks through plateaus. This includes working with a dietitian to recalibrate portion sizes, increasing protein intake to 1.6-2.0g per kilogram of body weight to preserve lean muscle mass, and incorporating resistance training at least twice weekly [3]. These lifestyle optimisations work synergistically with semaglutide's appetite-suppressing effects to restart weight loss.

When to Consider Alternative GLP-1 Treatments

Some patients respond better to different GLP-1 formulations or dual-action medications. Switching from Wegovy to a dual GIP/GLP-1 receptor agonist may provide additional weight loss in patients who have plateaued on semaglutide alone, though this decision requires careful clinical assessment by a UK prescriber [4]. Our clinical team evaluates your complete treatment history, current health status, and weight management goals to recommend the most appropriate next step.

Wegovy Dosing: Are You on the Right Strength?

The Wegovy dose escalation schedule is carefully designed to minimise gastrointestinal side effects whilst building up to the therapeutic 2.4mg weekly dose. Many patients who report Wegovy has stopped working are actually on sub-therapeutic doses—1.0mg or 1.7mg—where they paused escalation due to nausea or supply shortages [1]. Clinical trial data clearly demonstrates that weight loss correlates with dose: patients on 2.4mg lost an average of 14.9% body weight versus 11.6% on 1.7mg in STEP trials.

At Cured Pharmacy, all Wegovy doses are available—from the 0.25mg starter dose through to the 2.4mg maintenance pen. Our UK prescribers review your dosing history during consultation and, where clinically appropriate, can prescribe the next escalation step or restart the titration schedule if you've had treatment interruptions. Transparent upfront pricing means you'll see the cost (from £79.00) before completing your assessment, with no hidden fees.

Maximising Wegovy Effectiveness: Evidence-Based Strategies

Even patients on the correct Wegovy dose can optimise their results through specific behavioural strategies. Protein timing matters: consuming 30-40g of protein within 90 minutes of waking helps maintain lean muscle mass during weight loss and enhances satiety throughout the day [3]. This is particularly important on GLP-1 medications, which can reduce overall food intake to levels that risk muscle loss if protein isn't prioritised.

Sleep quality significantly impacts GLP-1 treatment outcomes. Poor sleep (less than 6 hours nightly) disrupts ghrelin and leptin regulation, the hunger hormones that Wegovy helps modulate [2]. Patients who improve sleep hygiene—maintaining consistent sleep schedules, reducing screen time before bed, and addressing sleep apnoea if present—often see renewed weight loss even without medication changes. Our clinical team can provide personalised guidance on these complementary strategies during your consultation.

Exercise and GLP-1 Medications

Resistance training becomes especially important during GLP-1 treatment. Whilst semaglutide preserves more lean muscle mass than diet-induced weight loss alone, adding progressive resistance exercise 2-3 times weekly further protects muscle tissue and may help overcome plateaus by increasing metabolic rate [3]. Cardiovascular exercise alone is less effective for breaking through weight loss plateaus on Wegovy.

Getting Wegovy When You Need It: All Doses Available

Supply consistency is crucial for maintaining Wegovy's effectiveness—treatment interruptions of just 2-3 weeks can require restarting at lower doses, delaying your progress by months. At Cured Pharmacy, we maintain stock of all Wegovy dose strengths (0.25mg, 0.5mg, 1.0mg, 1.7mg, and 2.4mg) to ensure uninterrupted treatment for our patients. Our pricing starts from £79.00, lower than typical UK market rates, with the exact cost displayed before you complete your clinical assessment.

The consultation process takes under 3 minutes online and is reviewed by our UK-registered clinical team, led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073). If your Wegovy prescription is approved, we dispense genuine UK-licensed medication with discreet packaging and prompt delivery. For patients experiencing plateaus, our prescribers can assess whether dose adjustment, treatment optimisation, or alternative options may be appropriate based on your individual circumstances and treatment history.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Perna, S., Alalwan, T. A., Alaali, Z., et al. (2019). The Role of Glutamine in the Complex Interaction between Gut Microbiota and Health: A Narrative Review. International Journal of Molecular Sciences, 20(20), 5232. https://doi.org/10.3390/ijms20205232 [accessed 13 August 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or making changes to your treatment plan. Weight loss results vary between individuals and depend on multiple factors including diet, exercise, and adherence to treatment.